NTSR1 and metastatic malignant neoplasm in the lymph nodes: Notably, mouse no. 2684 in the MVCAR#2 group had lymph node metastasis at early days post-NTR but was able to eventually sustain durable CR starting day 18 until the model termination (Figure 6H).